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1. Synthesis and characterization data of compounds 2-5 
General. Structural elucidation of the new compounds was accomplished by nuclear 
magnetic resonance spectroscopy (NMR). Proton and carbon-13 nuclear magnetic 
resonance (1H NMR or 13C NMR) spectra were recorded on a BRUKER AVANCE-300 
(1H 300 MHz, 13C 75 MHz), a Varian INOVA 300 (1H 300 MHz, 13C 75 MHz), a 
Varian INOVA 400 (1H 400 MHz, 13C 100 MHz) or a Varian SYSTEM 500 NMR (1H 
500 MHz, 13C 125 MHz) equipped with a 5 mm HCN cold probe. Silicon-29 nuclear 
magnetic resonance spectra (29Si NMR) were recorded on a Varian INOVA 400 (79.5 
MHz) spectrometer using Wildmad ́s PTFE-FEP (polytetra-fluoroethylene/fluorinated 
ethylene polypropylene copolymer) 5 mm tube liners. Chemical shifts of 1H (δH), 13C 
(δC) and 29Si in ppm were determined relative to tetramethylsilane (TMS). Data are 
presented as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, m 
= multiplet and/or multiple resonances, br = broad signal), integration, coupling 
constants in hertz (Hz), and assignment. One-dimensional NMR experiments (1H, 13C, 
and 29Si) were performed using standard Varian pulse sequences. Two-dimensional 
(2D) 1H-1H NMR experiments (gradient correlation spectroscopy gCOSY) were carried 
out with the following parameters: a delay time of 1 s, a spectral width of 3475.5 Hz in 
both dimensions, 2048 complex points in t2 and t4 transients for each of 128 time 
increments, and a linear prediction to 256. The data were zero-filled to 2048 x 2048 real 
points. 2D 1H-13C NMR experiments (gradient heteronuclear single quantum coherence: 
gHSQC, and gradient heteronuclear multiple-bond correlation: gHMBC) used the same 
1H spectral window, a 13C spectral window of 24132.7 Hz, a 1s relaxation delay, 1024 
data points, and 128 time increments, with a linear prediction to 256. The data were 
zero-filled to 4096 x 4096 real points. Typical numbers of transients per increment were 
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4 and 16, respectively. Activation parameters for compound 5 were measured in CDCl3 
by lineshape analysis using gNMR, in the temperature range 223 to 323 °C. The 
temperature was raised in steps of 5 °C, and 20 minutes were allowed for temperature 
equilibration before shimming at each temperature.  HPLC were recorded in an HPLC-
Alliance Waters 2695 coupled to a photodiode array from Waters 2996 and a mass 
spectrometer Micromass ZQ provided with a ESI source in positive mode with a 
quadrupole detector. A Sunfire C18 column (3.5 micron, 4.6×50 mm) was used. The 
products were eluted with acetonitrile/water gradients using 0.1% formic acid. Yields 
are given in relative area% of the absorbance measured at 287 nm (alkyl-azide 
absorbance), as deduced from the MS analysis of the peak. High resolution mass spectra 
(HRMS) were recorded on an Agilent 6520 Q-TOF instrument with a ESI source. 
Anhydrous solvents were prepared according to standard methods by distillation over 
drying agents or via elution through a PureSolv™ column drying system from 
Innovative Technology, Inc. All other solvents were of HPLC grade and were used as 
provided. All reactions were carried out with magnetic stirring and, if air or moisture 
sensitive, in oven-dried glassware under argon. Copper(I) catalyst [Cu(C186tren)]Br 
(C186tren = tris(2-dioctadecylaminoethyl)amine) was prepared according to a described 
procedure.1 
1,2-Bis(prop-2-yn-1-yloxy)benzene (2).2 To a solution of pyrocathecol (500 mg, 4.54 
mmol) in dry acetone (45 mL) under argon, was added finely powdered K2CO3 (2.51 g, 
18.16 mmol) and the suspension was stirred at 60 ºC for 30 min. To this mixture was 
added a solution of propargyl bromide in toluene (80 wt.%, 1.52 mL, 13.62 mmol) in 
portions during 1 h. After stirring at 60 ºC for 20 h, the mixture was cooled and filtered, 
and the filtrate was evaporated at reduced pressure. The resultant residue was purified 
by flash chromatography to afford 2 as a light-orange thick oil (0.696 g, 82% yield). 1H 
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NMR (CD3Cl, 300 MHz): δ 2.51 (t, 2H, J = 2.3 Hz, CCH), 4.76 (d, 4H, J = 2.3 Hz, 
ArOCH2), 6.85-7.18 (m, 4H, Ar). 
4-tert-Butylcalix[4]arenetetrapropargyl ether (3).3 To a flask containing 60% NaH in 
paraffin (370 mg, 9.24 mmol) under argon was added hexane (3 mL) and the resultant 
suspension was stirred for 5 min at room temperature and decanted. The resultant 
NaHsolid was suspended in anhydrous DMF (3 mL) and a solution of 4-tert-
butylcalix[4]arene (500 mg, 0.770 mmol) in DMF (2 mL + 1 mL rinse) was added 
dropwise at 0 ºC under good stirring. Considerable frothing was observed at this stage. 
After stirring for 40 min at 0 ºC, a solution of propargyl bromide in toluene (80 wt.%, 
0.85 mL, 7.7 mmol) was added and the mixture was stirred at room temperature for 24 
h. The reaction was quenched by adding MeOH (1 mL) dropwise and, after stirring for 
15 min, water was added (40 mL) and the product was extracted EtOAc (3 × 50 mL). 
The combined organic extracts were dried and the resultant dark residue was purified by 
flash chromatography to afford 3 as a light brown solid (383 mg, 62% yield). 1H NMR 
(CDCl3, 300 MHz): δ 1.09 (s, 36H, tBu), 2.48 (t, 4H, J = 2.3 Hz CH≡C), 3.18 (d, 4H, J 
= 12.8 Hz, Ar-CH2-Ar), 4.62 (d, 4H, J = 12.8 Hz, Ar-CH2-Ar), 4.81 (d, 8H, J = 2.3 Hz, 
CH2O), 6.80 (s, 8H, Ar). 
CuAAC reaction of 1 and 2. To a Schlenk flask fitted with a PTFE stopcock 
containing a solution of octakis(3-azidopropyl)octasilsesquioxane (1)4 (300 mg, 0.275 
mmol) and di-O-propargyl-o-cathecol (2) (11 mg, 0.055 mmol) in 16 mL of anhydrous 
toluene under argon was added [Cu(C186tren)]Br (10 mg, 0.0055 mmol) and iPr2NEt 
(60 mL, 0.385 mmol, 7.0 equiv). The stopcock was closed and the mixture was heated 
at 50 ºC under stirring for 21 h. The solvent was removed at reduced pressure and the 
crude residue was purified by automatic flash chromatography in a silica gel cartridge 
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using a toluene/MeOH (100:0 to 10:1 v/v gradient) to afford first 235 mg of unreacted 
octakis(3-azidopropyl)octasilsesquioxane 1 (98% of the total excess used) followed by 
the click products (61 mg), as a pale yellow oil. The HPLC-MS analysis of the isolated 
product showed it to be a mixture of 4a (85.12%), 6 (8.87%), and an unidentified 
silsesquioxane dimer containing two bis-triazolyl tethers (tetratriazolyl silsesquioxane 
dimers: TTSD, 6.01%). Characterization data for compound 4a: 1H NMR (CDCl3, 500 
MHz): 0.70-0.74 (m, 12H, SiCH2CH2CH2N3), 0.62-0.66 (m, 4H, SiCH2CH2CH2N-
triazole), 1.66-1.72 (m, 12H, SiCH2CH2CH2N3), 1.95-2.02 (m, 4H, SiCH2CH2CH2N-
triazole), 3.25-3.28 (m, 12H, CH2-N3), 4.37 (t, 4H, J = 7.1 Hz, CH2-triazole), 5.21 (s, 
4H, CH2-O), 7.00-7.02 (m, 2H Ar), 7.07-7.09 (m, 2H Ar), 7.80 (s, 2H, H-triazole). 13C 
NMR (125 MHz, CDCl3) δ 148.79, 144.37, 122.93, 122.52, 115.34, 63.96, 53.50, 52.58, 
24.31, 22.56, 9.10, 8.99. 29Si NMR (CDCl3, 79.5 MHz): d –67.00, –67.07, –67.52 (in 
2:1:1 intensity ratio, respectively). HRMS-ESI: Calc. for C36H59N24O14Si8 1274.2718, 
found 1275.2748 [M+H]+, 1297.2567 [M+Na]+.  
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Characterization data of the mixture of 4a, 6, and the minor TTSD products: 
1H·NMR (CDCl3, 500 MHz): δ 0.59-0.68 (m, 12H, SiCH2CH2CH2N3, 6/TTSD), 0.68-
0.79 (m, 12H, SiCH2CH2CH2N3, 4a), 0.83-0.91 (m,4H, SiCH2CH2CH2-triazole), 1.57-
1.76 (m, 12H, SiCH2CH2CH2N3),1.92-2.08 (m, 4H, SiCH2CH2CH2-triazole), 3.23-3.31 
(m, 12H, CH2-N3), 4.33 (t, 4H,J = 7.1 Hz, CH2-triazole, 6/TTSD), 4.37 (t, 4H, J = 7.1 
Hz, CH2-triazole, 4a and TTSD/6), 5.26, 5.27 and 5.28 (s, 4H, CH2-O, 6/TTSD, 
TTSD/6 and 4a), 6.89-6.94 (m, 2H, Ar, 6/TTSD), 6.95-6.98 (m, 2H Ar, 6/TTSD), 6.98-
7.04 (m, 2H Ar, 4a), 7.04-7.06 (m, 2H Ar, TTSD/6), 7.06-7.12 (m, 2H Ar, 4a), 7.14-
7.19 (m, 2H Ar, TTSD/6), 7.65 (s, 2H triazole, 6/TTSD), 7.67 (s, 2H, triazole, 
TTSD/6), 7.80 (s, 2H, 4a). 13C NMR (125 MHz, CDCl3) δ 9.0, 9.1, 9.1 (SiCH2), 22.6, 
22.6, 22.8 (SiCH2CH2 CH2N3), 24.1, 24.3 (SiCH2CH2CH2-triazol), 52.6 
(SiCH2CH2CH2-triazole), 53.5, 53,5 (SiCH2CH2CH2N3), 62.8, 63.6, 64.0 (CCH2O), 
113.7, 115.3, 115.6, 121.8, 122.2 (CH Ar), 122.5 (CH triazole), 122.9 (CH triazole), 
123.1 (CH triazole), 143.9 (Ctriazole), 144.3 (Ctriazole), 144.4 (Ctriazole), 148.0 
(CAr), 148.6 .(CAr), 148.8.(CAr). HRMS: Calc. for C36H59N24O14Si8 1274.2718, found 
1275.2748 [M+H]+, 1297.2567 [M+Na]+. Calc. for C60H106N48O26Si16  2362.4756, found 
2362.4718 [M+H]+. Calc. for C72H116N48O28Si16 2548.5467, found 2549.5431 [M+H]+, 
2572.5151 [M+Na]+. 
CuAAC reaction of 1 and 3: Synthesis of Janus-silsesquioxane 5. To a Schlenk flask 
fitted with a PTFE stopcock containing a solution of 1 (520 mg, 0.477 mmol) and 3 (77 
mg, 0.096 mmol) in 30 mL of anhydrous toluene under argon was added 
[Cu(C186tren)]Br (17 mg, 0.010 mmol) and iPr2NEt (200 mL, 1.150 mmol). The 
stopcock was closed and the mixture was heated at 50 ºC under stirring for 24 h. The 
solvent was removed at reduced pressure and the crude residue was purified by 
automatic flash chromatography in a silica gel cartridge using a toluene/MeOH (100:0 
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to 10:1) gradient to afford first 392 mg of unreacted octakis(3-
azidopropyl)octasilsesquioxane1 (99% of the total excess used) followed by compound 
9 (148 mg, 82% yield), as a pale cream-colored solid. 1H NMR (CDCl3, 500 MHz, –50 
ºC): d 0.68-0.84 (br m, 16H, 8 SiCH2), 0.77 (s, 18H, 2 t-Bu), 1.28 (s, 18H, 2 t-Bu), 1.65-
1.71 (br m, 8H, 4 SiCH2CH2CH2N3), 1.87 (br m, 4H, 2 SiCH2CH2CH2-triazole), 2.04 
(br. m, 4H, 2 SiCH2CH2CH2-triazole), 3.25 (d, 4H, J = 12.7 Hz, CH2 -calixarene), 3.29 
(t, 8H, J = 6.7 Hz, 4 CH2-N3), 3.86 (br m, 4H, 2 SiCH2CH2CH2-triazole), 4.36 (br m, 
4H, 2 SiCH2CH2CH2-triazole), 4.53 (d, 4H, J = 12.7 Hz, CH2 -calixarene), 4.69 (s, 4H, 
2 CH2-O), 4.83 (s, 4H, 2 CH2-O), 6.40 (s, 4H, 2 ArH-calixarene), 6.95 (s, 2H, 2 H-
triazole), 7.07 (s, 4H, 2 ArH-calixarene), 8.69 (s, 2H, 2 H-triazole). 1H NMR (CDCl3, 
500 MHz, 55 ºC): d 0.67-0.71 (m, 8H, 4 SiCH2CH2CH2N3), 0.74-0.83 (m, 8H, 4 
SiCH2CH2CH2-triazole), 1.01 (br s, 36H, 4 t-Bu), 1.62-1.69 (m, 8H, 4 
SiCH2CH2CH2N3), 1.93-2.01 (br m, 8H, 4 SiCH2CH2CH2-triazole), 3.18 (d, 4H, J = 
12.7 Hz, CH2 -calixarene), 3.21 (t, 8H, J = 6.7 Hz, 4 CH2-N3), 4.08 (br m, 8H, 4 
SiCH2CH2CH2-triazole), 4.55 (d, 4H, J = 12.7 Hz, CH2 -calixarene), 4.74 (s, 8H, 4 CH2-
O), 6.70 (br s, 8H, 4 ArH), 7.81 (br s, 4H, 4 H-triazole). 13C NMR (125 MHz, CDCl3, 
25 ºC, based on HSQC and HMBC spectra): δ 8.9 (SiCH2), 9.3 (SiCH2), 22.7 
(SiCH2CH2CH2N3), 24.6 (SiCH2CH2CH2-triazole), 29.9 (this signal correlates with a 
singlet at 1.24 ppm in the 1H NMR spectrum, which seems to be an impurity in our 
sample), 31.6 (CH2-calixarene), 31.8 (CH-t-Bu), 34.0 (Me3C), 52.0 (SiCH2CH2CH2-
triazole), 53.6 (SiCH2CH2CH2N3), 66.5 (CH2O), 125.3 (CH Ar), 125.4 (CH triazole), 
133.8 (CH2-CAr), 144.4 (tBu-CAr), 145.1 (C triazole), 153.2 (O-CAr). 29Si NMR 
(CDCl3, 79.5 MHz, 25 ºC): d –66.67, –67.05. HRMS-ESI Calc. for C80H112N24O16Si8 
1888.6842, found 1890.6931 [M+H]+, 1912.6775 [M+Na]+. 
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2. NMR spectra and HPLC-MS data 
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1H NMR (CDCl3, 300 MHz) of compound 2 
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1H NMR (CDCl3, 300 MHz) of compound 3 
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1H NMR (CDCl3, 500 MHz) of the click product isolated from the reaction of 1 and 2 (mainly 4a). 
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13C NMR (CDCl3, 125 MHz) of the click product isolated from the reaction of 1 and 2 (mainly 4a). 
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1H-13C HSQC (CDCl3, 500 MHz) of the click product isolated from the reaction of 1 and 2 (mainly 4a). 
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1H-13C HMBC (CDCl3, 500 MHz) of the click product isolated from the reaction of 1 and 2 (mainly 5a). 
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29Si NMR (CDCl3, 79.5 MHz) of the click product isolated from the reaction of 1 and 2 (mainly 5a).  
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HPLC-MS of the click products isolated from the reaction of 1 and 2 (TTSD: tetratriazolyl silsesquioxane dimer).
4a 
TTSD 6 
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HRMS-ESI of the click products isolated from the reaction of 1 and 2 (TTSD: tetratriazolyl 
silsesquioxane dimer). 
 
HRMS-ESI of compound 4a
TTSD 
4a 
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6  
HRMS-ESI of TTSD (TTSD: tetratriazolyl silsesquioxane dimer).
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1H NMR (CDCl3, 400 MHz, 55 ºC) of compound 5. 
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13C NMR (CDCl3, 125 MHz, 25 ºC) of compound 5. 
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1H-13C HSQC (CDCl3, 500 MHz, 55 ºC) of compound 5. 
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1H-13C HMBC (CDCl3, 500 MHz, 55 ºC) of compound 5. 
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29Si NMR (CDCl3, 79.5 MHz, 25 ºC) of compound 5 (relative intensities ca. 2:5; smaller signal shows larger broadening). 
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HRMS-ESI of compound 5
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3. Dynamic NMR study of compound 5 
In order to obtain the activation barrier for the conformational equilibrium of 5, rate 
constants were determined from the 1H NMR spectra over the temperature range 223-
323 K by using the line shape method with the gNMR program5 and considering a 
symmetric two-site exchange model. The enthalpy ΔH‡ and entropy ΔS‡ of activation 
were calculated using the Eyring equation. The resonance signal of the triazol proton (δ 
= 8.69, 6.94) and of the phenyl protons (δ = 7.06, 6.38) were used for the simulation. 
The simulated spectra with different rate obtained were compared with experimental 
spectra at different temperatures.  
Rln (hkr/κkT) = –ΔH*/T + ΔS* 
Eyring plot was obtained by plotting Rln (hkr/κkT) against inverse of temperature (1/T).  
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Figure 1S. Eyring plot for compound 5.  R2 = 0,998. ΔH* = –A (slope) = 7,17 +/– 0.07 
kcal mol–1. ΔS*= (y-intercept) = – 0.0196 +/–  2.5e–04 kcal K–1 mol–1. 
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Figure 2S. 1H NMR (400 MHz) spectra of 5 at varying temperature in CDCl3. 
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Figure 2S. 1H NMR (400 MHz) spectra of 5 at varying temperature in CDCl3. 
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Figure 2S. 1H NMR (400 MHz) spectra of 5 at varying temperature in CDCl3. 
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4. Molecular modeling calculations 
We have carried out a simple molecular modeling study of 5 in vacuum. First, we have 
run extensive energy minimizations using the MMFF94 force field6 starting from a 
large set of different initial conformations of the calixarene system and the linking 
chains connecting it to the silsesquioxane cage. The starting conformations were both 
manually set or obtained during different molecular dynamics trajectories performed 
with the same force field. The minimum energy conformer thus obtained was fully re-
optimized using the semiempirical PM3 method.7 
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